Skip to main content

leflunomide

Generic: LEFLUNOMIDE·Brand: ARAVA, LEFLUNOMIDE

leflunomide: 5 clinical trials tracked.

leflunomide evidence translation

What we can confirm

5 tracked trials

No verified listed developer

What it means

AI will separate confirmed drug evidence from unknown company context.

What to watch

Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected

Prepared research question

What is verified about leflunomide, and what remains unknown?

Run cited research

Traceable citations · Unknowns marked

See linked entities and source evidence3 indications · 1 study sponsors
Clinical Trials (5)

Phase I/II Study of Leflunomide in Combination With Decitabine for Treatment of Relapsed or Refractory (R/R) Myelodysplastic Syndromes (MDS)

NCT06923488·Phase 1/Phase 2
Recruiting

Primary endpoint: Percentage of incidences of regimen limiting toxicities (RLTs)

Interventionalopen26 targetStarted 2025-07Completion 2028-101 site · United StatesWest Virginia University

Post Authorization Safety Study on Assessment of Effectiveness of Additional Risk Minimization Measures Related to ARAVA® (Leflunomide) in Saudi Arabia

NCT06714461·SNY
Completed

Primary endpoint: Number of healthcare professionals who recall receiving and reading the additional risk minimization measures material for leflunomide distributed in 2022

Observational302 enrolledStarted 2025-05Completion 2026-051 site · FranceSanofi

Pilot Trial of Leflunomide in Combination With Steroids for the Treatment of Acute Graft-versus-Host Disease After Allogeneic Hematopoietic Cell Transplantation for Hematologic Malignancies

NCT05443425·Phase 1
Recruiting

Primary endpoint: Incidence of adverse events

Interventionalopen18 targetStarted 2023-06Completion 2027-011 site · United StatesCity of Hope Medical Center

A Phase 2 Trial of Leflunomide, Pomalidomide, and Dexamethasone for Relapsed/Refractory Multiple Myeloma

NCT04508790·Phase 2
Recruiting

Primary endpoint: Overall response

Interventionalopen29 targetStarted 2020-11Completion 2027-028 sites · United StatesCity of Hope Medical Center

Pilot Trial of Leflunomide in Patients With High-Risk Smoldering Multiple Myeloma

NCT04370483·Early Phase 1
Active, not recruiting

Primary endpoint: Progressive disease

Interventionalopen1 targetStarted 2020-10Completion 2026-111 site · United StatesCity of Hope Medical Center